Markets:

Overview

News

Currencies

International

Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

16.89 -0.54 (-3.10%)

Streaming Delayed Price Updated: 3:08 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about EyePoint, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Recap: EyePoint Pharmaceuticals Q4 Earnings ↗

March 03, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the...

Via Benzinga

Earnings Preview: EyePoint Pharmaceuticals ↗

March 02, 2022

EyePoint Pharmaceuticals (NASDAQ:EYPT) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement....

Via Benzinga

The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom ↗

December 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces Commercialization Agreement For Dexycu To Treat Post-...

Via Benzinga

Topics Intellectual Property Lawsuit

Why EyePoint Pharmaceuticals Shot 31% Higher Today ↗

November 17, 2021

The eyecare specialist has good momentum behind it as it prices a new round of capital raising.

Via The Motley Fool

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

61 Biggest Movers From Yesterday ↗

November 18, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...

Via Benzinga

Topics Initial Public Offering

Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher ↗

November 17, 2021

Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 17, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYP...

Via Benzinga

Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge ↗

November 17, 2021

Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96. The U.S. has...

Via Benzinga

Topics Stocks

42 Stocks Moving In Wednesday's Mid-Day Session ↗

November 17, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...

Via Benzinga

Topics Initial Public Offering

Mid-Morning Market Update: Markets Down; Lowe's Earnings Beat Estimates ↗

November 17, 2021

Following the market opening Wednesday, the Dow traded down 0.34% to 36,017.63 while the NASDAQ fell 0.19% to 15,944.13. The S&P also fell, dropping 0.23% to 4,690.06. The U.S...

Via Benzinga

Topics Earnings Stocks

EyePoint Pharmaceuticals Raises $100M Via Capital Raise At 5% Discount ↗

November 17, 2021

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has priced an underwritten public offering of 4.03 million at $13.75 per share and pre-funded warrants to purchase up...

Via Benzinga

The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment ↗

November 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea...

Via Benzinga

DLTR Stock: The Activist Investor News Shaking Up Dollar Tree Shares Today ↗

November 15, 2021

Dollar Tree (DLTR) stock is taking off on Monday thanks to news that an activist investor is pushing for change at the retail company.

Via InvestorPlace

41 Stocks Moving In Monday's Mid-Day Session ↗

November 15, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...

Via Benzinga

TCNNF Stock: The Positive Pot News That Has Trulieve Cannabis Shares Lighting Up Today ↗

November 15, 2021

Trulieve Cannabis (TCNNF) stock is taking off on Monday and we're diving into the pot news that has investors smiling today!

Via InvestorPlace

Topics Cannabis

EYPT Stock: The Clinical Trial News That Has EyePoint Pharma Investors Seeing Green Today ↗

November 15, 2021

EyePoint Pharmaceuticals (EYPT) stock is heading higher on Monday thanks to interim results from a Phase 1 clinical trial.

Via InvestorPlace

Why Are EyePoint Shares Trading Higher Today? ↗

November 15, 2021

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has announced six-month interim data from the Phase 1 trial of EYP-1901 in wet age-related macular degeneration (wet...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 15, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Via InvestorPlace

20 Stocks Moving in Monday's Pre-Market Session ↗

November 15, 2021

Gainers Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday. Bit Brother Limited (...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

EyePoint Sets its Sights on Developing Treatments Improving the Lives of Eye Disease Sufferers ↗

September 30, 2021

Photo Credit: EyePoint Pharmaceuticals Companies dedicated to improving the lives of the 2.2 billion people suffering from eye diseases are making incredible strides in developing...

Via Benzinga

EyePoint Sets its Sights on Continued Trial Success in Developing Treatments Improving the Lives of Eye Disorder Sufferers ↗

September 14, 2021

Photo by Brands&People on Unsplash Companies dedicated to improving the lives of the 2.2 billion people suffering from eye disorders are making incredible strides in...

Via Benzinga

EyePoint Pharmaceuticals: Q1 Earnings Insights ↗

May 05, 2021

Shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) moved higher by 2.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share...

Via Benzinga

EyePoint Pharmaceuticals's Earnings Outlook ↗

May 04, 2021

On Wednesday, May 05, EyePoint Pharmaceuticals (NASDAQ:EYPT) will release its latest earnings report. Decipher the announcement with Benzinga's help. What Are Earnings, Net...

Via Benzinga

If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing ↗

April 26, 2021

In this crazy Reddit-driven stock market, it's still important to understand why OCGN stock is hot. And why it's dangerous.

Via InvestorPlace

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.